Skip to main content
logo
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.7400
-0.0142 (-1.88%)
At close: Feb 27, 2026, 4:00 PM EST
0.7546
+0.0146 (1.97%)
After-hours: Feb 27, 2026, 7:48 PM EST

Citius Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-35.89-37.43-39.14-32.54-33.64-23.05
Depreciation & Amortization
0.720.210.210.190.180.16
Stock-Based Compensation
12.7910.8612.126.724.281.52
Other Operating Activities
-1.91-1.250.290.580.58-0.17
Change in Accounts Receivable
-4.05-----
Change in Inventory
-6.89-12.65-2.13---
Change in Accounts Payable
3.668.7721.76-0.11-0.58
Change in Other Net Operating Assets
-3.274.94-1.55-5.770.35-2.14
Operating Cash Flow
-34.84-26.55-28.2-29.06-28.36-24.25
Capital Expenditures
------0.01
Sale (Purchase) of Intangibles
-10.15-5.75-5---40
Investing Cash Flow
-10.15-5.75-5---40.01
Short-Term Debt Issued
-1.3----
Total Debt Issued
1.31.3----
Short-Term Debt Repaid
--0.3----0.17
Total Debt Repaid
-0.3-0.3----0.17
Net Debt Issued (Repaid)
11----0.17
Issuance of Common Stock
50.6132.313.815.03-127.71
Other Financing Activities
---3.83-1.2--7.07
Financing Cash Flow
51.6133.39.9713.83-120.47
Net Cash Flow
6.621-23.23-15.23-28.3656.21
Free Cash Flow
-34.84-26.55-28.2-29.06-28.36-24.26
Free Cash Flow Per Share
-2.39-2.40-4.19-4.80-4.85-5.58
Cash Interest Paid
0.20.19---0.04
Levered Free Cash Flow
-40.53-23.388.02-19.85-15.94-55.61
Unlevered Free Cash Flow
-40.26-23.218.02-19.85-15.94-55.61
Change in Working Capital
-10.551.05-1.69-4.010.24-2.72
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q